OPTN — OptiNose Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for OptiNose, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	144	111	94.2	73.7	84.5
Net Total Accounts Receivable
Net Total Receivables	23.4	35.4	33.9	19.9	26.4
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	181	160	140	105	126
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	8.01	5.4	3.24	2.29	2.88
Other Long Term Assets
Total Assets	189	166	144	108	129
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	52.2	59.2	179	177	163
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	182	188	201	194	169
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	6.79	-21.8	-56.6	-86.6	-40.4
Total Liabilities & Shareholders' Equity	189	166	144	108	129
Total Common Shares Outstanding